The North America Portable Alcohol And Drug For Abuse Testing Equipment Market, by Product Type (Breathalyzers (Semiconductor Based Breathalyzer, Infrared (IR) Based Breathalyzer, and Fuel Cell Based Breathalyzer), Oral Fluid Testing Devices, and Others), by Sample Type (Breath, Saliva, Blood, and Others), by End User (SWAT Team, Patrol Division, Game Warden, School Resource Officer, Transit/Railroad Officer, Correctional Officer, and Sheriff), and by Country (U.S. and Canada) is estimated to be valued at US$ 683.7 Million in 2021 and is projected to exhibit a CAGR of 5.9% during the forecast period (2021-2028).
The development of novel technologically advanced products by leading market players is expected to create a lucrative environment for other manufacturers to develop advanced breathalyzers and drug testing equipment. For instance, in March 2019, BACtrack, a U.S.-based manufacturer of breathalyzers, launched a remote monitoring app for alcoholism, a new remote monitoring service that will let a BACtrack user’s friends, family, or sponsors remotely check their sobriety level. The service is available as a subscription plan and all plans include the BACtrack Mobile device.
North America Portable Alcohol and Drug for Abuse Testing Equipment Market – Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic has affected various industries in North America. Key players operating in the North America portable alcohol and drug for abuse testing equipment market are facing major challenges on various fronts due to the COVID-19 pandemic. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported in North America, as of January 12, 2022, were approximately 312,173,462 confirmed cases with 312,173,462 deaths.
In addition, the Centers for Disease Control and Prevention (CDC) predicted that by 2021, a person with substance use disorder would be seriously unwell if infected with the SARS-CoV2 virus. However, according to a study published in Population Health Management in 2021, there had been a considerable reduction in prescription and illicit drug testing, with a 70% reduction in weekly test volume. As a result, during the pandemic, there is a greater demand for healthcare and public health organizations to participate in drug abuse testing in order to reduce adverse health outcomes among the majority of the world’s population, and the studied market is projected to benefit.